MedTrace Logo

Clinical Trial to Evaluate the Safety and Efficacy of "Theobromine Capsule" as an Antitussive in Acute Cougher

NCT01416480 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 332

Last updated 2011-08-15

No results posted yet for this study

Summary

The aim of this clinical trial is to evaluate the antitussive effect of "Theobromine capsule 300mg" in patients with acute bronchitis.

Conditions

  • Acute Bronchitis

Interventions

DRUG

Theobromine 300mg

Capsule, b.i.d.

DRUG

Levodropropizine 10mg

Syrup, t.i.d.

Sponsors & Collaborators

  • Ahn-Gook Pharmaceuticals Co.,Ltd

    lead INDUSTRY

Principal Investigators

  • Ki-Suck Jung, M.D. · Hallym University Medical Center

  • Soo-Taek Uh, M.D. · Soon Chun Hyang University Hospital

  • Jae Yeol Kim, M.D. · Chung-Ang University Medical Center

  • Young Kyoon Kim, M.D. · The Catholic University of Korea-St. Mary's Hospital

  • Sung Soon Lee, M.D. · Inje University Ilsan Paik Hospital

  • Yong Bum Park, M.D. · Kangdong Sacred Heart Hospital

  • Kwan Ho Lee, M.D. · Yeungnam University Hospital

  • Jung Hyun chang, M.D. · Ewha Womans University Mokdong Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-02-28
Completion
2011-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01416480 on ClinicalTrials.gov